The role of matrix metalloproteinases in vascular function: Implications for normal pregnancy and pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 9, 2004, Pages 931-939

  Merchant, Shaila J ^a   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ILOMASTAT; MATRIX METALLOPROTEINASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MATERNAL PLASMA; MESENTERIC ARTERY; MOUSE; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; ANIMALS; DIPEPTIDES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PLASMA; PRE-ECLAMPSIA; PREGNANCY; PROTEASE INHIBITORS;

EID: 4544316138     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00223.x     Document Type: Article

References (42)

1. Magness RR, Gant NF. Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension. Semin Perinatol 1994;18:45-69.
2. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-1451.
3. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505-2512.
4. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-2689.
5. Ashworth JR, Warren AY, Johnson IR, Baker PN. Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol 1998;105:459-461.
6. Hayman R, Warren A, Brockelsby J, Johnson I, Baker P. Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. Br J Obstet Gynaecol 2000;107:108-115.
7. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I, Baker P. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 1999;79:1101 -1111.
8. Gandley RE, Luedde AB, Daftary A, Hubel CA. AT1 receptor antagonist prevents preeclampsia plasma induced changes in vascular responsiveness of isolated mouse mesenteric arteries. J Soc Gynecol Investig 2001;8:74A.
9. Narumiya H, Zhang Y, Fernandez-Patron C, Guilbert LJ, Davidge ST. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001;20:185-194.
10. Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 1999;85:906-911.
11. Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 2000;87:670-676.
12. Brockelsby JCWT, Anthony F, Wellings R, Baker PN. Increased circulating levels of vascular endothelial growth factor in preeclampsia. Hypertens Pregnancy 1998;17:283-290.
13. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995;86:815-821.
14. Sharkey AM, Cooper JC, Balmforth JR, et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Investig 1996;26:1182-1185.
15. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia [discussion 1757-1759]. Am J Obstet Gynecol 1994;170:1752-1757.
16. Majka S, McGuire PG, Das A. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Investig Ophthalmol Vis Sci 2002;43:260-266.
17. Eichler W, Friedrichs U, Thies A, Tratz C, Wiedemann P. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Investig Ophthalmol Vis Sci 2002;43:2767-2773.
18. Rajavashisth TB, Liao JK, Galis ZS, et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999;274:11,924-11,929.
19. Coker ML, Jolly JR, Joffs C, et al. Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am J Physiol Heart Circ Physiol 2001;281:H543-H551.
20. Hill MA, Zou H, Potocnik SJ, Meininger GA, Davis MJ. Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity. J Appl Physiol 2001;91:973-983.
21. Meininger GA, Davis MJ. Cellular mechanisms involved in the vascular myogenic response. Am J Physiol 1992;263:H647-H659.
22. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
23. Davisson RL, Hoffmann DS, Butz GM, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002;39:337-342.
24. Merrill DC, Granwehr BP, Davis DR, Sigmund CD. Use of transgenic and gene-targeted mice to model the genetic basis of hypertensive disorders. Proc Assoc Am Phys 1997;109:533-546.
25. Veerareddy S, Cooke CL, Baker PN, Davidge ST. Vascular adaptations to pregnancy in mice: effects on myogenic tone. Am J Physiol Heart Circ Physiol 2002;283:H2226-H2233.
26. Cook JL, Zhang Y, Davidge ST. Vascular function in alcohol-treated pregnant and nonpregnant mice. Am J Physiol Regul Integr Comp Physiol 2001;281:R1449-R1455.
27. Halpern W, Osol G, Coy GS. Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 1984;12:463-479.
28. Baker PN, Davidge ST, Roberts JM. Plasma from women with pre-eclampsia increases endothelial cell nitric oxide production. Hypertension 1995;26:244-248.
29. Baker PN, Davidge ST, Barankiewicz J, Roberts JM. Plasma of pre-eclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 1996;27:56-61.
30. Hao JL, Nagano T, Nakamura M, Kumagai N, Mishima H, Nishida T. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases. Exp Eye Res 1999;68:565-572.
31. Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 1994;94:2177-2182.
32. Scalera F, Schlembach D, Beinder E. Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol 2001;99:172-178.
33. Taylor RN, de Groot CJ, Cho YK, Lim KH. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:17-31.
34. Merchant SJ, Narumiya H, Zhang Y, Guilbert LJ, Davidge ST. The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. Hypertens Pregnancy 2004;23:47-60.
35. Davidge ST, Baker PN, Roberts JM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol 1995;269:H1106-H1112.
36. Agren MS, Mirastschijski U, Karlsmark T, Saarialho-Kere UK. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol 2001;10:337-348.
37. Fernandez-Patron C, Radomski MW, Davidge ST. Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol 2000;278:H1473-H1479.
38. Novak J, Opett SL, Conrad KP. Matrix metalloproteinase-2 mediates the reduced myogenic reactivity during pregnancy and in relaxin-treated nonpregnant rats. J Soc Gynecol Investig 2003;10:245A.
39. Novak J, Ramirez RJ, Gandley RE, Sherwood OD, Conrad KP. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am J Physiol Regul Integr Comp Physiol 2002;283:R349-R355.
40. Kerchner LJ, Fisher MC, Conrad KP. The pregnancy hormone relaxin upregulates matrix metalloproteinase-2 (MMP-2) in small renal arteries from rats. J Soc Gynecol Investig 2003;10:244A.
41. Jeyabalan A, Danielson LA, Kerchner LJ, Conrad KP. Vascular matrix metalloproteinase (s) mediates renal vasodilation and hyperfiltration in relaxin-treated rats. J Soc Gynecol Investig 2003;10:198A-199A.
42. Simonson MS. Endothelins: multifunctional renal peptides. Physiol Rev 1993;73:375-411.